Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
243070.KQ
STRONG BUYREMOVEHuons Co., Ltd. · Healthcare · South Korea · $210M · Avg Vol: $1M/d
Huons is a South Korean pharmaceutical company. It operates primarily in local generic and aesthetic markets, lacking the global scale, regulatory moats, and high-utilization CDMO pricing power required for our healthcare exposure.
COMPANY DESCRIPTION
Huons Co., Ltd. is a South Korean pharmaceutical company that develops, manufactures, and distributes generic drugs, specialty therapeutics, and medical devices. The company is a market leader in local anesthetics and has successfully diversified into aesthetic products, including dermal fillers and botulinum toxin. Its competitive moat is driven by a highly diversified product portfolio, robust domestic distribution networks, and expanding global export channels.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 320.7M | 359.5M | 384.4M | 404.3M | 8.0% |
| EPS | 1.69 | 1.24 | 2.77 | 1.62 | 2.38 | 8.9% |
| Shares | — | 11.9M | 12.0M | 12.0M | 11.7M | -2.4% |
| Debt | — | 68.5M | 79.9M | 116.4M | 116.2M | 19.2% |
| Equity | — | 183.9M | 211.9M | 225.3M | 243.5M | 9.8% |
| Op CF | — | 23.0M | 34.0M | 34.2M | 29.3M | 8.3% |
| Inv CF | — | -45.6M | 2.0M | -70.3M | -10.9M | — |
| Fin CF | — | 5.0M | -13.7M | 28.4M | -16.8M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 243070.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 243070.KQ | Huons Co., Ltd.(you) | $210M | 80 | STRONG BUY |
| 008490.KS | Suheung Co., Ltd. | $132M | 79 | BUY |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | $331M | 85 | STRONG BUY |
| 033270.KS | Korea United Pharm Inc. | $166M | 91 | STRONG BUY |
| 001630.KS | Chong Kun Dang Holdings Corp. | $124M | 91 | STRONG BUY |
| 206650.KQ | EuBiologics Co., Ltd. | $214M | 59 | HOLD |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | $153M | 96 | STRONG BUY |
| 016580.KS | Whan In Pharm Co.,Ltd. | $118M | 92 | STRONG BUY |
| 096760.KS | JW Holdings Corporation | $166M | 100 | STRONG BUY |
| 023910.KQ | Daihan Pharmaceutical Co.,Ltd. | $96M | 90 | STRONG BUY |
Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%